Your browser doesn't support javascript.
loading
Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma.
Beishuizen, Auke; Mellgren, Karin; Andrés, Mara; Auperin, Anne; Bacon, Chris M; Bomken, Simon; Burke, G A Amos; Burkhardt, Birgit; Brugieres, Laurence; Chiang, Alan K S; Damm-Welk, Christine; d'Amore, Emanuele; Horibe, Keizo; Kabickova, Edita; Khanam, Tasneem; Kontny, Udo; Klapper, Wolfram; Lamant, Laurence; Le Deley, Marie-Cecile; Loeffen, Jan; Macintyre, Elizabeth; Mann, Georg; Meyer-Wentrup, Friederike; Michgehl, Ulf; Minard-Colin, Veronique; Mussolin, Lara; Oschlies, Ilske; Patte, Catherine; Pillon, Marta; Reiter, Alfred; Rigaud, Charlotte; Roncery, Leila; Salaverria, Itziar; Simonitsch-Klupp, Ingrid; Uyttebroeck, Anne; Verdu-Amoros, Jaime; Williams, Denise; Woessmann, Wilhelm; Wotherspoon, Andrew; Wrobel, Grazyna; Zimmermann, Martin; Attarbaschi, Andishe; Turner, Suzanne D.
Affiliation
  • Beishuizen A; Division of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; The Netherlands and Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.
  • Mellgren K; Department of Paediatric Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Andrés M; Department of Pediatric Oncology, University Hospital Le Fe, Valencia, Spain.
  • Auperin A; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Bacon CM; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Bomken S; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Burke GAA; Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
  • Burkhardt B; Department of Pediatric Hematology, Oncology, and BMT, University Hospital Muenster, Münster, Germany.
  • Brugieres L; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Chiang AKS; Department of Pediatrics & AdolescentMedicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Damm-Welk C; Pediatric Hematology and Oncology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • d'Amore E; Department of Pathological Anatomy, San Bortolo Hospital, Vicenza, Italy.
  • Horibe K; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Kabickova E; Department of Pediatric Hematology and Oncology, Charles University & University Hospital Motol, Prague, Czech Republic.
  • Khanam T; Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
  • Kontny U; Section of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatric and Adolescent Medicine, RWTH Aachen University Hospital, Aachen, Germany.
  • Klapper W; Institute of Pathology, Hematopathology Section, University of Schleswig-Holstein, Kiel, Germany.
  • Lamant L; Université Toulouse III-Paul Sabatier, Laboratoire d'Excellence Toulouse Cancer-TOUCAN, Équipe Labellisée La Ligue Contre Le Cancer, Inserm, Toulouse, France.
  • Le Deley MC; Biostatistics Unit, Gustave Roussy Cancer Campus, Villejuif, France.
  • Loeffen J; Division of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Macintyre E; Onco-hematology, Université Paris Cité and Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Mann G; Pediatric Hematology and Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Meyer-Wentrup F; Division of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Michgehl U; Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
  • Minard-Colin V; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Mussolin L; Istituto di Ricerca Pediatrica Città della Speranza, Padua, Italy; Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University Hospital, Padova, Italy.
  • Oschlies I; Institute of Pathology, Hematopathology Section, University of Schleswig-Holstein, Kiel, Germany.
  • Patte C; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Pillon M; Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University Hospital, Padova, Italy.
  • Reiter A; Department of Pediatric Hematology and Oncology, Justus Liebig-University Giessen, Giessen, Germany.
  • Rigaud C; Department of Pediatric Hematology, Oncology, and BMT, University Hospital Muenster, Münster, Germany.
  • Roncery L; St Anna Children's Hospital, Department of Paediatric Haematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Salaverria I; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Simonitsch-Klupp I; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Uyttebroeck A; Department of Pediatric Hematology and Oncology, University Hospital Leuven,KU Leuven, Leuven, Belgium.
  • Verdu-Amoros J; Department of Pediatric Hematology and Oncology, University Hospital Valencia, Valencia, Spain.
  • Williams D; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Woessmann W; Pediatric Hematology and Oncology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Wotherspoon A; Department of Pathology, The Royal Marsden Hospital, London, UK.
  • Wrobel G; Bone Marrow Transplantation and Pediatric Hematology and Oncology, Wroclaw Medical University, Wroclaw, Poland.
  • Zimmermann M; Hannover Medical School, Department of Pediatric Hematology and Oncology, Hannover, Germany.
  • Attarbaschi A; St Anna Children's Hospital, Department of Paediatric Haematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Turner SD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK; Central European Institute for Technology, Masaryk University, Brno, Czech Republic. Electronic address: sdt36@cam.ac.uk.
Lancet Haematol ; 10(3): e213-e224, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36858678
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin Limits: Adult / Child / Humans Country/Region as subject: Europa Language: En Journal: Lancet Haematol Year: 2023 Document type: Article Affiliation country: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin Limits: Adult / Child / Humans Country/Region as subject: Europa Language: En Journal: Lancet Haematol Year: 2023 Document type: Article Affiliation country: Países Bajos